fda warning letters compounding semaglutide september 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Planet Money | The carnitine Weight Loss Program type:Tirzepatide (GLP-1 + GIP)

fda warning letters compounding semaglutide september 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Planet Money | The carnitine Weight Loss Program type:Tirzepatide (GLP-1 + GIP)

Planet Money | The vast majority of employer health plans do not cover GLP-1s for weight loss. But roughly 20% do, many believing it will help their... | Instagram

In the phase 2 trial, the combined 8 mg group was already showing approximately 10-12% body weight reduction by week eight to ten

carnitine

Weight Loss Program type:Tirzepatide (GLP-1 + GIP)

No injections, no refrigeration